SUSQUEHANNA INTERNATIONAL GROUP, LLP - POSEIDA THERAPEUTICS INC ownership

POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 94 filers reported holding POSEIDA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of POSEIDA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$217,746
+40.3%
91,490
+3.8%
0.00%
Q2 2023$155,179
-92.3%
88,170
-86.5%
0.00%
Q1 2023$2,006,294
+39.2%
651,394
+139.5%
0.00%
Q4 2022$1,441,473
+88.2%
271,976
+25.3%
0.00%
Q3 2022$766,000
+233.0%
217,001
+543.4%
0.00%
Q4 2021$230,000
+75.6%
33,726
+87.4%
0.00%
Q3 2021$131,000
-14.4%
18,000
+17.6%
0.00%
Q2 2021$153,000
-67.0%
15,300
-68.4%
0.00%
Q1 2021$463,00048,4510.00%
Other shareholders
POSEIDA THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,043,267$9,254,0002.96%
SECTORAL ASSET MANAGEMENT INC 1,053,779$9,347,0000.80%
Pentwater Capital Management LP 4,879,490$43,281,0000.56%
Vivo Capital, LLC 926,449$8,218,0000.48%
Boxer Capital, LLC 1,251,055$11,097,0000.38%
Ikarian Capital, LLC 228,000$2,022,0000.15%
Perceptive Advisors 787,745$6,987,0000.10%
Rock Springs Capital Management LP 367,499$3,260,0000.08%
PURA VIDA INVESTMENTS, LLC 148,949$1,321,0000.07%
PIPER SANDLER & CO. 8,298$74,0000.06%
View complete list of POSEIDA THERAPEUTICS INC shareholders